← Eichor
Study identifier: NCT07361315 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Development and Online Evaluation of an Online Course for Parasomnias

Condition: Sleep Terror · Sleepwalking · Nightmare Disorder  ·  Sponsor: University of Manitoba

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Parasomnias are unwanted events during sleep. These refer to sleep terrors, sleepwalking, sleep eating, nightmares, and movement during REM sleep. There are few systematic behavioral treatments for these problems and individuals with them often receive little education about self-management. This research examines and evaluates the effectiveness of a 4 week online course providing education and guidance about managing parasomnias. The primary outcomes are improvement in parasomnia frequency and distress. The secondary outcomes are improvements in work and social adjustment, mood, anxiety, stress level, fatigue, sleepiness, insomnia, and cognitive interference.

This description comes directly from the study's public registry record.

Talk to the study team

Cassidy Santos Research Coordinator, B.A.  ·  1-204--891-6235  ·  csantos17@hsc.mb.ca

Norah Vincent, PhD  ·  1-204-787-3272  ·  nvincent@hsc.mb.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Psychealth Center, University of ManitobaWinnipeg, Manitoba, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07361315